163 related articles for article (PubMed ID: 15773414)
1. [Effectiveness of Russian vaccines in the prophylaxis of virus hepatitis B].
Solov'eva IL; Kusel'man AI; Kalmanova VP; Kostinov MP
Zh Mikrobiol Epidemiol Immunobiol; 2005; (1):100-5. PubMed ID: 15773414
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity and safety of combined intradermal recombinant Hepatitis B with BCG vaccines at birth.
Carniel EF; Morcillo AM; Blotta MH; Da Silva MT; Mazzola TN; Antonio MA; Zanolli ML; Netto AA; Higashi HG; Raw I; Vilela MM
Vaccine; 2008 Jan; 26(5):647-52. PubMed ID: 18155811
[TBL] [Abstract][Full Text] [Related]
3. [Experience with vaccine prophylaxis of hepatitis B among different groups of children].
Moskovskaia IA; Kuzina LE; Anichkina TV; Aleshin IK; Ul'ianova LA; Kuzin SN
Zh Mikrobiol Epidemiol Immunobiol; 2003; (2):42-6. PubMed ID: 12886606
[TBL] [Abstract][Full Text] [Related]
4. [Adaptability of the anti-hepatitis-B vaccine Recombivax HB to the Piazza protocol for the mass vaccination of newborn infants].
Piazza M; Abrescia N; Picciotto L; Cotugno M; Vegnente A; Iorio R; Cimmino L
Boll Soc Ital Biol Sper; 1992 Jul; 68(7):483-9. PubMed ID: 1482565
[TBL] [Abstract][Full Text] [Related]
5. Five-year follow-up of a prospective randomized trial of hepatitis B recombinant DNA yeast vaccine vs. plasma-derived vaccine in children: immunogenicity and anamnestic responses.
Lai CL; Wong BC; Yeoh EK; Lim WL; Chang WK; Lin HJ
Hepatology; 1993 Oct; 18(4):763-7. PubMed ID: 8406348
[TBL] [Abstract][Full Text] [Related]
6. [The efficacy of recombinant vaccines against hepatitis B and the results of their use in a schedule for pediatric prophylactic inoculations].
Gorbunov MA; Pavlova LI; Titov IA; Bektimirov TA; Selezneva VP; Shitikova OIu; Mamontova TV; Indikova IN
Zh Mikrobiol Epidemiol Immunobiol; 1997; (6):55-8. PubMed ID: 9460867
[TBL] [Abstract][Full Text] [Related]
7. [Vaccination against hepatitis B].
Desgrandchamps D; Siegrist CA
Soz Praventivmed; 1998; 43 Suppl 1():S37-40, S111-4. PubMed ID: 9833264
[TBL] [Abstract][Full Text] [Related]
8. Phase I clinical trial in healthy adults of a nasal vaccine candidate containing recombinant hepatitis B surface and core antigens.
Betancourt AA; Delgado CA; Estévez ZC; Martínez JC; Ríos GV; Aureoles-Roselló SR; Zaldívar RA; Guzmán MA; Baile NF; Reyes PA; Ruano LO; Fernández AC; Lobaina-Matos Y; Fernández AD; Madrazo AI; Martínez MI; Baños ML; Alvarez NP; Baldo MD; Mestre RE; Pérez MV; Martínez ME; Escobar DA; Guanche MJ; Cáceres LM; Betancourt RS; Rando EH; Nieto GE; González VL; Rubido JC
Int J Infect Dis; 2007 Sep; 11(5):394-401. PubMed ID: 17257877
[TBL] [Abstract][Full Text] [Related]
9. New vaccination strategies for low- and non-responders to hepatitis B vaccine.
Rendi-Wagner P; Wiedermann G; Stemberger H; Kollaritsch H
Wien Klin Wochenschr; 2002 Mar; 114(5-6):175-80. PubMed ID: 12238305
[TBL] [Abstract][Full Text] [Related]
10. [Antibodies against hepatitis B after vaccination in health workers].
Pérez-López JA; García-Elorriaga G; Del Rey-Pineda G; Manjarrez-Téllez B
Salud Publica Mex; 2011; 53(3):205-6. PubMed ID: 21829884
[No Abstract] [Full Text] [Related]
11. Anti-HBs levels in infants of hepatitis B carrier mothers after delayed active immunization with recombinant vaccine concomitant with DTP-polio vaccine: is there need for a second dose of HBIg? Dutch Study Group on Prevention of Neonatal Hepatitis B.
Grosheide PM; del Canho R; Voogd M; Heijtink RA; Schalm SW
Vaccine; 1994 Sep; 12(12):1059-63. PubMed ID: 7998413
[TBL] [Abstract][Full Text] [Related]
12. Comparison of a triple antigen and a single antigen recombinant vaccine for adult hepatitis B vaccination.
Young MD; Gooch WM; Zuckerman AJ; Du W; Dickson B; Maddrey WC
J Med Virol; 2001 Jul; 64(3):290-8. PubMed ID: 11424117
[TBL] [Abstract][Full Text] [Related]
13. A boost to hepatitis B vaccine: no need for boosters.
Aggarwal R
Natl Med J India; 2005; 18(6):313-4. PubMed ID: 16483032
[No Abstract] [Full Text] [Related]
14. [HBs antigenemia and vaccination against hepatitis B virus: attention to chronology of markers].
Beaulieu S; Lopez Y; Eugène C
Presse Med; 2000 Oct; 29(32):1762-3. PubMed ID: 11098272
[No Abstract] [Full Text] [Related]
15. Safety and immunogenicity of a modified process hepatitis B vaccine in healthy adults ≥50 years.
Gilbert CL; Klopfer SO; Martin JC; Schödel FP; Bhuyan PK
Hum Vaccin; 2011 Dec; 7(12):1336-42. PubMed ID: 22185811
[TBL] [Abstract][Full Text] [Related]
16. Active immunization of children with leukemias and lymphomas against infection by hepatitis B virus.
Rokicka-Milewska R; Jackowska T; Sopyło B; Kacperska E; Seyfried H
Acta Paediatr Jpn; 1993 Oct; 35(5):400-3. PubMed ID: 8256623
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity, antibody persistence, and safety of the 60 μg hepatitis B vaccine in hemodialysis patients: a multicenter, randomized, double-blind, parallel-controlled trial.
Feng Y; Shi X; Shi J; Gao L; Liu G; Cheng Y; Pan M; Li C; Wang J; Guo X; Zhang Y; Liang X; Wang S
Expert Rev Vaccines; 2017 Oct; 16(10):1045-1052. PubMed ID: 28803502
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B vaccination of premature infants: a reassessment of current recommendations for delayed immunization.
Losonsky GA; Wasserman SS; Stephens I; Mahoney F; Armstrong P; Gumpper K; Dulkerian S; West DJ; Gewolb IH
Pediatrics; 1999 Feb; 103(2):E14. PubMed ID: 9925860
[TBL] [Abstract][Full Text] [Related]
19. Successful immune response to a recombinant hepatitis B vaccine in children after liver transplantation.
Duca P; Del Pont JM; D'Agostino D
J Pediatr Gastroenterol Nutr; 2001 Feb; 32(2):168-70. PubMed ID: 11321387
[TBL] [Abstract][Full Text] [Related]
20. The significance of immunocompromised condition in the prophylaxis of hepatitis B in chronic renal insufficiency.
Gasparović V; Puljević D; Gjurasin M; Delimar N; Borcić D; Gasparović H; Mihaljević I
Acta Med Croatica; 1993; 47(2):61-5. PubMed ID: 7505130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
